PT2214683E - Unidade de dosagem para a saúde do cérebro - Google Patents
Unidade de dosagem para a saúde do cérebroInfo
- Publication number
- PT2214683E PT2214683E PT88449525T PT08844952T PT2214683E PT 2214683 E PT2214683 E PT 2214683E PT 88449525 T PT88449525 T PT 88449525T PT 08844952 T PT08844952 T PT 08844952T PT 2214683 E PT2214683 E PT 2214683E
- Authority
- PT
- Portugal
- Prior art keywords
- composition
- per unit
- unit dose
- unit dosage
- brain health
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2007/050529 WO2009057994A1 (en) | 2007-11-02 | 2007-11-02 | Unit dosage for brain health |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2214683E true PT2214683E (pt) | 2013-10-17 |
Family
ID=39591591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT88449525T PT2214683E (pt) | 2007-11-02 | 2008-10-27 | Unidade de dosagem para a saúde do cérebro |
Country Status (9)
Country | Link |
---|---|
US (1) | US8283336B2 (pt) |
EP (2) | EP2537521A1 (pt) |
CN (1) | CN101842103A (pt) |
BR (1) | BRPI0819138B8 (pt) |
DK (1) | DK2214683T3 (pt) |
ES (1) | ES2430846T3 (pt) |
PL (1) | PL2214683T3 (pt) |
PT (1) | PT2214683E (pt) |
WO (2) | WO2009057994A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010000224A (es) | 2007-06-26 | 2010-05-03 | Nutricia Nv | Mejoramiento de la memoria en individuos con mini-examen de estado mental de 24-26. |
WO2011047095A1 (en) * | 2009-10-13 | 2011-04-21 | Martek Biosciences Corporation | Reducing the risk of pathological effects of traumatic brain injury |
US20110086914A1 (en) * | 2009-10-13 | 2011-04-14 | Bailes Julian E | Methods for Treating Traumatic Brain Injury |
DE102011008016A1 (de) * | 2011-01-06 | 2012-07-12 | Johannes F. Coy | Schokoladenmasse |
EP2773339A1 (en) * | 2011-10-31 | 2014-09-10 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
WO2013066153A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
WO2013066151A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
WO2013066152A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Method for improving executive function |
US20150044138A1 (en) * | 2012-03-02 | 2015-02-12 | N.V. Nutricia | Method for improving functional synaptic connectivity |
GB201205856D0 (en) * | 2012-04-02 | 2012-05-16 | Randall Jeremy A P | Food supplement to support brain function |
WO2014171813A1 (en) * | 2013-04-17 | 2014-10-23 | N.V. Nutricia | Nutritional composition for improving brain function in phenylketonuria |
KR20180130501A (ko) * | 2016-02-22 | 2018-12-07 | 뉴트리셔스 비브이 | 신경퇴행성 질병의 예방 또는 치료를 위한 조성물 |
WO2021019580A1 (en) * | 2019-07-26 | 2021-02-04 | Prosol S.P.A. | Composition comprising 5'-ribonucleotides for use in the treatment of alzheimer's disease |
CN117956908A (zh) | 2021-09-17 | 2024-04-30 | N·V·努特里奇亚 | 适合作为营养组合物或补充剂用于患有脑相关障碍、衰退或疾病的动物的固体组合物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
AU769645B2 (en) | 1987-05-29 | 2004-01-29 | Abbott Laboratories | Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation |
DK0483070T3 (da) | 1990-10-24 | 1995-07-17 | Sandoz Nutrition Ltd | Næringsmæssigt komplet fødevaresammensætning indeholdende hydrolyseret opløselig fiber |
ES2123903T5 (es) | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
US5792501A (en) * | 1996-04-15 | 1998-08-11 | The Iams Company | Queen's milk replacer |
US5780081A (en) * | 1996-10-28 | 1998-07-14 | Nestec S.A. | Fortification of food with calcium and process of making |
US6288116B1 (en) * | 1998-05-13 | 2001-09-11 | Novartis Nutrition Ag | Method of administration of a nutritional product to a person having renal failure |
US6245379B1 (en) * | 1998-09-30 | 2001-06-12 | The Iams Company | Method of administering a milk substitute to critical care animals |
US6630452B2 (en) * | 2000-02-17 | 2003-10-07 | Wyeth | Nutritional formulation containing prebiotic substances |
US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
DE10057976B4 (de) | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
CA2594883A1 (en) * | 2001-04-30 | 2002-11-07 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Pharmaceutically active uridine esters |
EP1634599A1 (en) * | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
AU2005285090A1 (en) | 2004-09-15 | 2006-03-23 | Massachusetts Institute Of Technology | Compositions containing uridine, and methods utilizing same |
WO2006127620A2 (en) * | 2005-05-23 | 2006-11-30 | Massachusetts Institute Of Technology | Compositions containing pufa and methods of use thereof |
CA2614473C (en) | 2005-07-08 | 2016-05-03 | Martek Biosciences Corporation | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
US7829126B2 (en) * | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
EP1800675B1 (en) * | 2005-12-23 | 2011-05-18 | N.V. Nutricia | Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia |
EP1803358A1 (en) * | 2005-12-28 | 2007-07-04 | Laboratorios Ordesa, S.L | Infant immunological formula |
-
2007
- 2007-11-02 WO PCT/NL2007/050529 patent/WO2009057994A1/en active Application Filing
-
2008
- 2008-10-27 EP EP12184651A patent/EP2537521A1/en not_active Withdrawn
- 2008-10-27 US US12/740,435 patent/US8283336B2/en active Active
- 2008-10-27 CN CN200880114299A patent/CN101842103A/zh active Pending
- 2008-10-27 EP EP08844952.5A patent/EP2214683B9/en not_active Revoked
- 2008-10-27 WO PCT/NL2008/050672 patent/WO2009058005A2/en active Application Filing
- 2008-10-27 PL PL08844952T patent/PL2214683T3/pl unknown
- 2008-10-27 BR BRPI0819138A patent/BRPI0819138B8/pt not_active IP Right Cessation
- 2008-10-27 PT PT88449525T patent/PT2214683E/pt unknown
- 2008-10-27 DK DK08844952.5T patent/DK2214683T3/da active
- 2008-10-27 ES ES08844952T patent/ES2430846T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP2537521A1 (en) | 2012-12-26 |
DK2214683T3 (da) | 2013-10-21 |
PL2214683T3 (pl) | 2013-12-31 |
EP2214683B9 (en) | 2013-12-25 |
EP2214683A2 (en) | 2010-08-11 |
EP2214683B1 (en) | 2013-07-10 |
US20100261669A1 (en) | 2010-10-14 |
ES2430846T3 (es) | 2013-11-22 |
CN101842103A (zh) | 2010-09-22 |
BRPI0819138B8 (pt) | 2021-05-25 |
WO2009058005A2 (en) | 2009-05-07 |
WO2009058005A3 (en) | 2009-07-16 |
WO2009057994A1 (en) | 2009-05-07 |
BRPI0819138B1 (pt) | 2019-09-03 |
US8283336B2 (en) | 2012-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2214683E (pt) | Unidade de dosagem para a saúde do cérebro | |
TWI451846B (zh) | 含斛黃素組合物 | |
PL3599237T3 (pl) | Kompozycja farmaceutyczna inhibitora syntazy glukozyloceramidowej eliglustatu do leczenia choroby Gauchera obejmującego dostosowanie indywidualnej dawki terapeutycznej do metabolizmu P450 pacjenta | |
ES2541528T3 (es) | Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma | |
CN101754694A (zh) | 对日常生活活动进行支持 | |
HRP20130406T1 (hr) | Medikamenti s aktivnošä†u prema receptoru hm74a | |
MX2007004882A (es) | Derivados de xantina con actividad de receptor de hm74a. | |
TN2011000437A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
HRP20130811T1 (en) | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia | |
TW200801029A (en) | Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture | |
TW200706182A (en) | Combination immediate release controlled release levodopa and carbidopa dosage forms | |
SG166820A1 (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
MX363023B (es) | Formulaciones orales de analogos de citidina y metodos para usar los mismos. | |
FI2170104T4 (fi) | Ravintokoostumus esioireisille dementiapotilaille | |
IL190150A0 (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease | |
MX339684B (es) | Metodos, compuestos, composiciones y vehiculos para suministrar el acido 3-amino-1-propanosulfonico. | |
MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
JPWO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
Paul et al. | The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine | |
TW200505880A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
MX2008002065A (es) | Derivados de pirazola como agentes terapeuticos. | |
TW200508210A (en) | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
US20180028473A1 (en) | Nutrients solutions | |
WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
NZ598174A (en) | Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |